Загрузка...
Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
PURPOSE: Colistin alone may not be sufficient for treating carbapenem-resistant Acinetobacter baumannii (CRAB); thus, efforts are needed to increase treatment success rates. We compared the effects of colistin plus carbapenem therapy versus colistin monotherapy in treating pneumonia caused by CRAB a...
Сохранить в:
| Опубликовано в: : | Infect Drug Resist |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6934122/ https://ncbi.nlm.nih.gov/pubmed/31920347 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S234211 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|